Deal Corner
January 30, 2017
Morgan Stanley PE Asia invests in ZCL Chemicals Limited

DEAL BRIEF

Morgan Stanley Private Equity Asia, one of the leading private equity investors in Asia-Pacific, has acquired minority stake, for a total consideration of USD 25 million (approximately), in ZCL Chemicals Limited (formerly Zandu Chemicals Ltd.), one of the fastest growing pharmaceutical companies in India, headquartered in Mumbai and engaged in manufacturing, supplying and selling specialty chemicals, advanced drug intermediates and active pharmaceutical ingredients (APIs).

Press coverage relation to this transaction is available at here and here.

OUR ROLE

We, at Nishith Desai Associates, acted as the transaction counsel to Morgan Stanley PE Asia and advised on strategic and legal aspects of the transaction including the negotiations and deal documentation.

Disclaimer

The contents of this hotline should not be construed as legal opinion. View detailed disclaimer.

We expressly clarify that this communication is not a solicitation or an invitation of any sort whatsoever from Nishith Desai Associates or any of its members to create an attorney-client relationship. This communication is not intended to be a source of advertising and the recipient should always seek the advice of competent counsel licensed to practice in the recipient's country/state.

This is not a Spam mail. You have received this mail because you have either requested for it or someone must have suggested your name. Since India has no anti-spamming law, we refer to the US directive, which states that a mail cannot be considered Spam if it contains the sender's contact information, which this mail does. In case this mail doesn't concern you, please unsubscribe from mailing list.

NDA Connect

Connect with us at events, 
conferences and seminars.

Deal Corner

January 30, 2017

Morgan Stanley PE Asia invests in ZCL Chemicals Limited

DEAL BRIEF

Morgan Stanley Private Equity Asia, one of the leading private equity investors in Asia-Pacific, has acquired minority stake, for a total consideration of USD 25 million (approximately), in ZCL Chemicals Limited (formerly Zandu Chemicals Ltd.), one of the fastest growing pharmaceutical companies in India, headquartered in Mumbai and engaged in manufacturing, supplying and selling specialty chemicals, advanced drug intermediates and active pharmaceutical ingredients (APIs).

Press coverage relation to this transaction is available at here and here.

OUR ROLE

We, at Nishith Desai Associates, acted as the transaction counsel to Morgan Stanley PE Asia and advised on strategic and legal aspects of the transaction including the negotiations and deal documentation.

Disclaimer

We expressly clarify that this communication is not a solicitation or an invitation of any sort whatsoever from Nishith Desai Associates or any of its members to create an attorney-client relationship. This communication is not intended to be a source of advertising and the recipient should always seek the advice of competent counsel licensed to practice in the recipient's country/state.

This is not a Spam mail. You have received this mail because you have either requested for it or someone must have suggested your name. Since India has no anti-spamming law, we refer to the US directive, which states that a mail cannot be considered Spam if it contains the sender's contact information, which this mail does. In case this mail doesn't concern you, please unsubscribe from mailing list.

NDA Connect

Connect with us at events, 
conferences and seminars.